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Fucci2a: A bicistronic cell cycle reporter that
allows Cre mediated tissue speciﬁc expression
in mice
Richard Lester Mort1, Matthew Jonathan Ford1, Asako Sakaue-Sawano2, Nils Olof Lindstrom3, Angela Casadio1,
Adam Thomas Douglas1, Margaret Anne Keighren1, Peter Hohenstein1,3, Atsushi Miyawaki2, and Ian James Jackson1,3,*
1MRC Human Genetics Unit; MRC IGMM; University of Edinburgh; Western General Hospital Edinburgh; Scotland, UK; 2Laboratory for Cell Function and Dynamics; Advanced
Technology Development Group; Brain Science Institute; RIKEN; Wako-city, Saitama, Japan; 3The Roslin Institute; The University of Edinburgh; Easter Bush, Midlothian; Scotland, UK
Keywords: cell cycle, Fucci, Fucci2, Fucci2a, kidney, lung, melanoblast
Abbreviations: BrdU, 5-bromo-20-deoxyuridine; DAPI, 40, 6-diamidino-2-phenylindole; DMEM, Dulbeccos modified eagle
medium; ECACC, European Collection of Cell Cultures; EMMA, European Mouse Mutant Archive; FACS, Fluorescence-activated
cell sorting; Fucci, Fluorescent Ubiquitination-based Cell Cycle Indicator; GMEM, Glasgow minimum essential medium; hESC,
Human embryonic stem cell; IRES, Internal ribosomal entry site; LIF, leukemia inhibitory factor; mAG, Monomeric Azami Green;
mESC, Mouse embryonic stem cell; mKO2, Monomeric Kusabira Orange; RBDB, Riken Bioresource Center DNA Bank; T2A,
Thosea asigna virus 2A peptide.
Markers of cell cycle stage allow estimation of cell cycle dynamics in cell culture and during embryonic development.
The Fucci system incorporates genetically encoded probes that highlight G1 and S/G2/M phases of the cell cycle
allowing live imaging. However the available mouse models that incorporate Fucci are beset by problems with
transgene inactivation, varying expression level, lack of conditional potential and/or the need to maintain separate
transgenes—there is no transgenic mouse model that solves all these problems. To address these shortfalls we re-
engineered the Fucci system to create 2 bicistronic Fucci variants incorporating both probes fused using the Thosea
asigna virus 2A (T2A) self cleaving peptide. We characterize these variants in stable 3T3 cell lines. One of the variants
(termed Fucci2a) faithfully recapitulated the nuclear localization and cell cycle stage speciﬁc ﬂorescence of the original
Fucci system. We go on to develop a conditional mouse allele (R26Fucci2aR) carefully designed for high, inducible,
ubiquitous expression allowing investigation of cell cycle status in single cell lineages within the developing embryo.
We demonstrate the utility of R26Fucci2aR for live imaging by using high resolution confocal microscopy of ex vivo lung,
kidney and neural crest development. Using our 3T3 system we describe and validate a method to estimate cell cycle
times from relatively short time-lapse sequences that we then apply to our neural crest data. The Fucci2a system and
the R26Fucci2aR mouse model are compelling new tools for the investigation of cell cycle dynamics in cell culture and
during mouse embryonic development.
Introduction
The cell cycle in the early embryo is tightly regulated but as
development progresses control diversifies and increased asyn-
chronous divisions lead to variation within and between tissues.1
Differential proliferation within tissues has been implicated in
branching morphogenesis of the developing lung and kidney and
in limb bud formation.2–4 Furthermore proliferation is thought
to contribute to the active migration of the neural crest during
embryogenesis.5 The mechanisms underlying these processes are
poorly understood and a lineage restricted cell cycle reporter sys-
tem would be a powerful tool to help dissect them.
The E3 ligases APCCdh1 and SCFSkp2 ubiquitinate a number
of proteins, targeting them for degradation during the cell cycle.
SCFSkp2 is both a substrate and a direct inhibitor of APCCdh1
meaning that their levels (and the levels of the proteins they ubiq-
uitinate) oscillate reciprocally. APCCdh1 is active in late M and
G1 phases while SCFSkp2 is active in S and G2.6–8 Geminin and
Cdt1 play roles in the regulation of replication origins and are
direct substrates of APCCdh1 and SCFSkp2 respectively and
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therefore also oscillate.9,10 The Fucci (Fluorescent Ubiquitina-
tion-based Cell Cycle Indicator) probe pair consists of a fusion of
monomeric Kusabira Orange (mKO2) with a truncated hCdt1
containing amino acids 30-120 and a fusion of monomeric
Azami Green and the 110 amino acid N-terminus of the hGemi-
nin protein. The mKO2-hCdt1(30/120) probe accumulates dur-
ing G1 phase and is degraded at the G1-S transition. The mAG-
hGem(1/110) probe accumulates during S/G2/M phases and is
rapidly degraded prior to cytokinesis.11 Fucci2 replaces the fluo-
rescent proteins mKO2 and mAG with mCherry and mVenus
respectively.12
A number of Fucci mouse lines exist. CAG-Fucci is not
inducible and is composed of 2 lines; CAG-mKO2-hCdt1(30/
120) and CAG-mAG-hGem(1/110) generated by random trans-
genesis.11 Addition transgenics of this nature are prone to
transgene inactivation causing variegated/low expression levels
in some tissues.13 This problem may be compounded by the
independent integrations of each transgene; low expression has
been reported for these lines in several tissues.14 R26p-Fucci2
is a constitutive allele composed of a bidirectional transgene
driving mCherry-hCdt1(30/120) and mVenus-hGem(1/110)
using a fragment of the mouse Rosa26 promoter. It is also gen-
erated by random transgenesis and is homozygous lethal; only
hemizygotes are used resulting in a waste of non-transgenic
offspring. R26-mCherry-hCdt1(30/120) and R26-mVenus-
hGem (1/110) are separate inducible lines recombined into the
Rosa26 locus and driven by the endogenous promoter, the
R26-mCherry-hCdt1(30/120) allele suffers from low expression
levels.14 Of these existing mouse models no Cre-recombinase
inducible single construct has been developed. One approach
to achieve this goal would be to produce a bicistronic con-
struct driven by a strong ubiquitously expressed promoter tar-
geted to a safe harbor such as the mouse Rosa26 or HPRT
locus.15,16
One method to achieve bicistronic gene expression might be
to use a viral internal ribosomal entry site (IRES) utilizing a
cap-dependent initiation of translation for the first open-read-
ing-frame (ORF) and a cap-independent mechanism for trans-
lation of the second (for a review see Hellen and Sarnow,
2001).17 However rarely are equimolar amounts of protein pro-
duced using an IRES sequence.18 An attractive alternative to the
IRES are the viral 2A peptides, these short peptide sequences
can be inserted between genes to create a single ORF that yields
separate proteins by ribosomal skipping during translation.19
2A peptides share a highly conserved C-terminal region at
which the cleavage event occurs between the penultimate gly-
cine residue and the final proline, if the cleavage efficiency is
high enough a near 1:1 stoichiometric relationship between the
gene products can be achieved.20 The CAG promoter is a strong
synthetic promoter incorporating the cytomegalovirus early
enhancer element; the promoter, first exon and first intron of
the chick b-actin gene; and the b-globin splice acceptor
sequence.21 CAG has been used widely to drive transgene
expression in mouse embryos but can be sensitive to position
effects therefore careful choice of the integration site is
required. The most widely used safe harbor for transgene
insertion in mouse is the Rosa26 locus, identified as a site of
ubiquitous gene expression.22,23 Rosa26 has subsequently been
used to target many reporters such as b-galactosidase, CFP
and YFP to produce ubiquitously expressed inducible alleles
both driven by the endogenous promoter15,24 and by CAG
for higher expression.25,26 The orientation of such constructs
within the Rose26 locus can directly impact on their expres-
sion level.27,28
We describe here the design and validation of a bicistronic
version of Fucci2 (Fucci2a) incorporating the Thosea asigna virus
2A peptide (T2A) and the production of transgenic mice by tar-
geting an inducible version of Fucci2a driven by the CAG pro-
moter to the mouse Rosa26 locus. We use these tools to
investigate cell cycle dynamics in 3T3 cells, the developing lung
and kidney and migrating mouse neural crest derived cells. Fur-
thermore we describe and validate a generally applicable method
to estimate cell cycle times from relatively short time lapse
sequences and apply this method to our neural crest data. The
Fucci2a cell line, constructs and the R26Fucci2aR mouse model
we describe are compelling new tools for the investigation of cell
cycle dynamics in cell culture and during mouse embryonic
development.
Results
The Fucci2 probe mVenus-hGem(1/110) is sensitive
to C-terminal modification
We built a bicistronic version of Fucci2 incorporating both
probes into a single construct; mVenus-hGem(1/110) and
mCherry-hCdt1(30/120) fused using the Thosea asigna virus 2A
(T2A) self cleaving peptide sequence. The transcript from this
construct should predictably produce equimolar quantities of
both cell cycle probes. Figure 1 outlines the design and validation
of the constructs. As 2A peptides cleave asymmetrically, and add
the majority of amino acid residues to the C-terminus of the pro-
tein located at the N-terminal position (see Fig. 1A) 2 versions of
the Fucci2a construct were designed to test the effects of this
addition on each probe. The 2 fusions had the Fucci2 probes
arranged so that either mCherry-hCdt1(30/120) or mVenus-
hGem(1/110) were in the N-terminal position. We tested the
constructs in 3T3 cells by generating stable lines containing a sin-
gle integration of either fusion (Fig. 1B–J). Analysis of these cell
lines revealed that mCherry-hCdt1(30/120) localized normally
to the nucleus despite the additional amino acids whereas the
nuclear localization of mVenus-hGem(1/110) was partially dis-
rupted. We confirmed this by quantification of the nuclear to
cytoplasmic ratio of mVenus-hGem(1/110) in each cell line
(Fig. 1K) and demonstrated an increase in this ratio (reflecting
an increase in the cytoplasmic level of mVenus-hGem(1/110)).
Figure 1L summarizes the results of this initial validation; we
concluded that mVenus-hGem(1/110) was partially mis-local-
ized on C-terminal modification. Consequently the construct
with mCherry-hCdt1(30/120) in the N-terminal position was
chosen for further validation and will subsequently be referred to
as Fucci2a.
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3T3 cell cycle time is modulated by serum concentration
and is concordant between daughter pairs
To validate the behavior of the stable Flp-Fucci2a 3T3 cells
and demonstrate the utility of Fucci2a in quantitative cell cycle
analyses, we performed live time-lapse imaging experiments and
fluorescence activated cell sorting (FACS). Figure 2 summarizes
the key results. Flp-Fucci2a 3T3 cells proceeded normally
through the cell cycle; detectable levels of the mVenus and
mCherry reporters appeared to be coordinated and cyclic; cells
were either mCherry positive (red) in G1, mVenus positive
(green) in S/G2/M or double positive (yellow) for a brief period
in the transition between these phases (See Movie S1 and
Fig. 2A–B). FACS analysis using DAPI to quantify DNA con-
tent (Fig. 2C) showed clearly that the mCherry and mVenus
positive cell populations were associated with the G1 and S/G2/
M fractions of the cell cycle in the same manner as the original
Fucci constructs.11 To obtain quantitative measurements of the
lengths of the cell cycle phases highlighted by Fucci2a, we per-
formed fluorescence live imaging of Flp-Fucci2a 3T3 cells in the
presence of 10% or 15% fetal calf serum (FCS). The results were
subjected to image analysis to measure the length of the mCherry
(G1 – red), mVenus (S/G2/M – green) and double positive (G1/
S – yellow) peaks. Figure 2D summarizes these results. The
mean (§ 95% CI) cell cycle time in the Flp-Fucci2a 3T3 cells
grown in the presence of 10% FCS was 25.62 § 2.69 hours (n
D 20 mitoses). When the cells were grown in the presence of
15% FCS the cell cycle time was 20.23 § 2.20 hours (n D 20
mitoses) representing a statistically significant reduction. The
Figure 1. Design and validation of bicistronic Fucci2a expression constructs. (A) The Fucci2 probes mVenus-hGem(1/110) and mCherry-hCdt1(30/120)
were fused using the Thosea asigna virus 2A peptide, the core T2A sequence is highlighted in blue and was inserted between the Fucci2 probes in both
orientations. The T2A sequence comprises 18 amino acids, cleavage occurs between the ﬁnal glycine and proline (arrow in A). In addition to these
17 amino acids 2 amino acids were added to create an MfeI restriction site for cloning; in total the 50 Fucci probe has 19 amino acids added to its
C-terminus while the 30 Fucci probe incorporates one additional amino acid. (B) The resulting 2 versions of Fucci2a were termed Fucci2a-5C3V
(50 mCherry-hCdt1(30/120) 30 mVenus-hGem(1/110)) and Fucci2a-5V3C (50 mVenus-hGem(1/110) 30 mCherry-hCdt1(30/120)) and were targeted to a
single locus in NIH 3T3 cells using the Flp-In system to create 2 isogenic polyclonal Fucci2a cell lines. (C–J) Imaging of the resulting stable cell lines
revealed that the addition of the 19 T2A amino acids resulted in mVenus-hGem(1/110) partially loosing its nuclear localization, mCherry-hCdt1(30/120)
remained nuclear with the same addition (compare C to G and D to H). (K) Quantiﬁcation of the nuclear to cytoplasmic ratio for both Fucci2 probes for
the 2 Fucci2a cell lines revealed a statistically signiﬁcant increase in the nuclear to cytoplasmic ratio of mVenus-hGem(1/110) in the Fucci2a-5V3C cell
line (2-way ANOVA PD<0.0001, Tukey’s HSD P< 0.0001). (L) Summary of the initial characterization showing that only mVenus-hGem(1/110) is sensitive
to the additional 18 amino acids. Error bars in K D 95% Conﬁdence interval.
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G1 (red) phase was also significantly reduced from 12.7 §
2.57 hours to 8.90 § 1.81 hours for 10% versus 15% serum (n
D 20 mitoses in both cases). The other cell cycle phases (S/G2/
M and G1/S) followed the same trend but showed smaller reduc-
tions that were not statistically significant. Interestingly there
was a remarkable concordance between the cell cycle length of
the 2 daughters of a mitosis over a roughly three-fold-range of
cell cycle times from 15 up to 40 hours (Fig. 3). The positive
correlation between cell cycle times of a given daughter pair was
highly statistically significant (Spearman’s rank order correlation
P < 0.001, rs D 0.7) whereas there was no correlation between
the same data if the pairs were assigned randomly (Spearman’s
rank order correlation PD 0.9, rsD¡0.04).
Cell cycle time (Tc) can be estimated using the length
of the mVenus positive phase
In an asynchronously cycling population, containing no non-
cycling cells, the ratio of cells in a given cell cycle phase to the
total number of cells is equal to the ratio of the length of that
phase to the total cell cycle length. This relationship has been
exploited using double labeling of cells with thymidine analogs
to estimate cell cycle length (Tc).
29–31 By measuring the number
of cells in S-phase (Scells) and the number that have left S-phase
(Lcells) in the time between thymidine analog injections (Ti), the
length of S-phase (Ts) can be derived in the following manner:
TsD Ti=.Lcells=Scells/
and Tc can be derived as:
TcD Ts=.Scells=Pcells/
Where Pcells is the total number of cells. Having accurately mea-
sured the mean cell cycle time in our 3T3 time-lapse experiments
we decided to evaluate the accuracy of this theoretical approach.
We reasoned that we could derive a cell cycle time from the
Figure 2. Live imaging of Fucci2a stable 3T3 cell line. (A) A montage of a time-lapse sequence showing nuclear expression of Fucci2a throughout the
progressing cell cycle. mCherry accumulates during G1 and is lost during the G1/S transition as mVenus reaches its peak. Both probes are lost at mitosis
(asterisk in ﬁnal panel). (B) Plot of the relative intensities of the Fucci2a probes during a single cell cycle showing the mCherry and mVenus peaks.
(C) Conﬁrmation by FACS that the Fucci2a probes accurately predict cell cycle phase deﬁned by DAPI staining for DNA content. Cells positive for mCherry
peak in the G1/2n population, while mVenus positive cells peak in the 4n population immediately prior to mitosis. (D) Quantiﬁcation of the length of cell
cycle phases by live cell imaging and image analysis. Increasing the serum concentration from 10–15% resulted in a statistically signiﬁcant shortening
of the cell cycle (students t-test with Bonferroni correction P < 0.001) and a reduction in the length of G1 ( students t-test with Bonferroni correction
P < 0.05). Tc D cell cycle time; Tg1 D G1 length; Tsg2mD S/G2/M length; Ts D G1/S transition length. Error bars in D D 95% Conﬁdence interval.
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length of S/G2/M (Tsg2m), the number of cells in S/G2/M
(Nsg2m) and the total number of cells (Nall) as follows:
TcD Tsg2m=.Nsg2m=Nall/
Using this approach we calculated cell cycle times (mean § 95%
CI) of 25.70 § 2.50 hours and 18.40 § 1.48 hours for the 10%
and 15% serum treated populations respectively. The difference
between these values was highly statistically significant (students
t-test P < 0.001) and was in extremely close agreement with the
values calculated from measuring complete mitoses described
above.
R26Fucci2a embryonic stem cells do not accumulate
mCherry-hCdt1(30/120) during G1 phase
Fucci2a Cre recombinase activatable mouse embryonic stem
cell (mESC) lines were made by targeting the Fucci2a construct
to the Rosa26 locus creating the R26Fucci2aR allele. Figure 4A
and B outlines the strategy used. Rather than rely on the endoge-
nous Rosa26 promoter, Fucci2a expression was driven by the
CAG promoter.21 The construct was orientated in the opposite
direction to the endogenous promoter to avoid transcriptional
interference. 28 To test Fucci2a expression in the resulting mESC
lines the construct was activated by transfection with a Cre
expressing plasmid thus excising the neomycin resistance cassette
to create the R26Fucci2a allele (Fig. 4C). After transfection cells
were plated at low density and individual clones picked and
tested for G418 sensitivity. In R26Fucci2a mESCs clones, main-
tained under standard conditions in the presence of leukemia
inhibitory factor (LIF), mVenus could be observed in a high pro-
portion of nuclei (Fig. 4D) whereas mCherry positive nuclei
could only be detected in a few differentiating cells at the periph-
ery of some colonies. FACS analysis of single G418 sensitive
R26Fucci2a mESC clones revealed a substantial population of
cells that did not appear to be positive for either mCherry or
mVenus (Fig. 4F). Subsequent FACS analysis using DAPI to
quantify DNA content revealed that the majority of this negative
cell population were in G1 (Fig. 4H). To investigate whether
this was a problem with the expression construct or a mESC spe-
cific effect, R26Fucci2a ES cells were differentiated by LIF with-
drawal and addition of retinoic acid (RA). After 4 days of culture
mCherry became detectable in a large proportion of nuclei (com-
pare Fig 4D to E and F to G). DAPI staining and cell cycle analy-
sis by FACS to quantify DNA content showed that the majority
of the emerging mCherry positive population were in G1 (com-
pare Fig. 4H and I).
Regionalized variation in Fucci2a cell cycle status
in R26Fucci2aRC/Tg/CAG-CreCve embryos
R26Fucci2aR ES cells were used to generate the global, bicis-
tronic, Cre-activatable reporter mouse line R26Fucci2aR. No
Fucci2a expression was observed in R26Fucci2aR animals due to
the strong transcriptional stop sequences contained in the floxed-
Neo-pA stop cassette (data not shown). Ubiquitous Fucci2a
expression was examined in R26Fucci2aRC/Tg/CAG-CreCve
embryos, Figure 5 summarizes some of the patterns observed.
We observed strong Fucci2a expression at all time points exam-
ined including trunk, forelimbs, lung and kidney at E11.5
(Fig. 5A–P). Further investigation of the developing limb bud at
E11.5 showed there was a clear pattern in the distribution of cells
in G1/G0 (red) and S/G2/M (green). In the condensing mesen-
chyme of the future digits there was a predominance of cells in
Figure 3. Comparison of mitosis times for daughter cell pairs. (A) Corre-
lation of mitosis times for daughter cell pairs was highly statistically sig-
niﬁcant (Spearman’s rank order correlation P < 0.001, rs D 0.7) (B) There
was no correlation between the same data if the pairs were assigned ran-
domly (Spearman’s rank order correlation P D 0.9, rs D ¡0.04). Tc D cell
cycle time.
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G1/G0 (red, Fig. 5F) while in the interdigitary mesenchyme,
cells continued to proliferate and were predominately in S/G2/M
(green, Fig. 5E). Such regionalized differences in proliferation
were also evident in the developing lung and kidney cultured
from E11.5. In the lung the actively branching regions were pre-
dominantly in S/G2/M (green, Fig. 5I) while the future bron-
chial regions were beginning to exit the cell cycle and were
predominantly populated by cells in G1/G0 (red, Fig. 5J). In the
developing kidney, cells in S/G2/M (green) were primarily
located within the ureteric bud as well as in clusters of cells
immediately adjacent to the bud (Fig. 5M). It was clear from
inspection of the brightfield channel that these clusters were early
nephron structures at either renal vesicle or comma-shaped body
stage (Fig. 5P). In contrast the cap mesenchyme, containing the
nephron progenitor cells, was largely composed of cells in G1/G0
(red, Fig. 5N).
Rapid proliferation at the budding tip drives branching
morphogenesis in the embryonic lung and kidney
We used time lapse imaging of tissue from R26Fucci2aC/Tg/
CAG-CreCve mice to investigate cell cycle progression during lung
Figure 4. Mouse embryonic stem cells expressing Fucci2a. A single copy of the Fucci2a transgene under the control of the CAG promoter was inserted
into the Rosa26 locus by homologous recombination in mouse embryonic stem cells (mESCs). (A) Targeting construct used, a stop cassette containing a
loxP ﬂanked neomycin resistance gene and polyadenylation sequence was inserted between CAG and Fucci2a, this construct was inserted in the reverse
orientation to the endogenous Rosa26 promoter to avoid transcriptional interference. (B) The targeted R26Fucci2aR inducible allele, screening for correct
homologous recombination was done using PCR across the 50 and 30 homology arms of the targeting construct. To test the R26Fucci2aR ES cell lines
they were transfected with a Cre-recombinase expressing plasmid (pPGK-Cre), plated at low density and screened for G418 sensitive Fucci2a expressing
clones (R26Fucci2a). (C) The targeted R26Fucci2a allele after Cre-mediated excision of the ﬂoxed-Neo-pA stop cassette. (D) R26Fucci2a ES cells showed
high levels of mVenus in the majority of cells but very few mCherry positive cells were evident. (E) However on withdrawal of Lif and culture in the pres-
ence of retinoic acid (RA) for 4 days high proportions of mCherry positive cells were evident. (F and G) FACS analysis showed that there were a large pro-
portion of cells negative for both markers in R26Fucci2a ES cells and that on Lif removal and RA treatment the negative population was reduced and an
mCherry positive population became apparent. (H and I) Quantiﬁcation of DNA content by DAPI staining followed by FACS analysis showed clearly that
the majority of G1 cells were negative for mCherry in the R26Fucci2a clone. After Lif withdrawal and culture in the presence of RA for 4 days, a G1 popula-
tion of mCherry positive cells became apparent.
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Figure 5. Ubiquitous expression of Fucci2a in R26Fucci2aRC/Tg/CAG-CreCve embryos. (A–D) Whole mount R26Fucci2aRC/Tg/CAG-CreCve embryonic trunk at
E11.5. Fucci2a expression and localization is clearly apparent with red green and yellow cells evident. (E–H) Whole mount R26Fucci2aRC/Tg/CAG-CreCve
embryonic limb bud at E11.5. Clear areas of mCherry-hCdt1(30/120) positive cells are evident in the condensing mesenchyme that will go on to form the
future bone while the interdigitary areas are still highly proliferative. (I–L) A R26Fucci2aRC/Tg/CAG-CreCve E11.5 embryonic lung cultured for 24 hours,
there is a clear bias in the distribution of cells in G1 and S/G2/M. The actively branching regions of the developing lung are highly proliferative while the
future bronchial regions have begun to drop out of the cell cycle as demonstrated by the high proportion of G1 cells in these regions (dotted regions in
I, J, K). (M–P) A dissected R26Fucci2aRC/Tg/CAG-CreCve E11.5 embryonic kidney cultured for 24hrs. Cells in S, G2, and M-phase were primarily detected
within the ureteric bud and in clusters of cells immediately adjacent to the bud comprising early nephron structures. The cap mesenchyme was largely
populated by cells in G1.
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and kidney development. Whole lung and kidney samples were
dissected from E11.5 embryos and cultured. In the lung it was
possible to observe the process of branching morphogenesis of
the respiratory epithelium (Fig. 6; Movie S2). Branching was
observed via both bifurcation of the tip of an epithelial branch
(Fig. 6A, B, G, and H) and by domain branching from the side
of an existing branch (Fig. 6D and E). In both cases cells at the
distal tip of an epithelial branch were observed to be highly prolif-
erative, demonstrated by the high proportion of S/G2/M phase
cells (Fig. 6C) labeled with mVenus (green). This localized prolif-
eration appears to drive elongation of an epithelial branch into
the surrounding mesen-
chyme which was
composed of cells pre-
dominantly positive for
mCherry and therefore
in G1/G0 (Fig. 6F)
suggesting a much
lower rate of prolifera-
tion. As an epithelial
branch elongated, cells
of the proximal region
began to slow their cell
cycles ending in a stable
G1/G0 state and per-
durance of the mCherry
label (Fig. 6I).
In the kidney, time
lapse images were cap-
tured of the developing
cap-mesenchyme, ure-
teric bud tips, ureteric
bud stalk, as well as
developing nephrons
(Fig. 6; Movie S3). The
cap-mesenchyme popu-
lation consisted of a mix-
ture of cells positive for
mVenus (green) and
mCherry (red) and
therefore in both S/G2/
M and G1/G0. When
nephrons progressed
through development
and formed the more
mature structure of S-
shaped bodies (Fig. 7D–
F) a large proportion of
cells remained in S/G2/
M (green). However,
presumptive podocytes
in the visceral epithelium
were beginning to enter
G1/G0 (red). Cells
within the ureteric bud
successively entered G1/
G0 (red) as the ureteric bud tips grew further away. In more mature
glomerular structures almost all podocytes were in G1/G0 (red,
Fig. 7G–I; Movie S3). The nephron progenitor niche, i.e. the cap
mesenchyme, contained cells in S/G2/M (green), and G1/G0 (red)
that kept cycling throughout the culture period. The ureteric bud
tips primarily contained cells in S/G2/M (green) but stalk regions
became progressively populated by cells in G1/G0 (red). Renal
vesicles (early nephrons) forming adjacent to the ureteric bud tips
contained a high proportion of cells in S/G2/M (green). As the
nephrons developed further through S-shaped body stage, the
distal and medial segments (identified by their morphology) were
Figure 6. Live confocal imaging of branching morphogenesis during lung development. Lungs were cultured ex vivo
from E11.5. (A and B) An elongating branch of lung epithelium begins to bifurcate at right angles to the plane of imag-
ing (white dots and arrows in B). (C) Cells in the distal tip of the extending branch of lung epithelium are proliferating
rapidly shown by the high proportion of S/G2/M (green) nuclei. (D and E) The left and right branches elongate driven
by proliferation at the growing tip. By 34.5 hours a daughter branch can be seen to emerge from the left parent branch
by domain branching (blue dot and arrow in E). (F) In contrast to the epithelial branch the surrounding mesenchyme is
composed of cells predominantly in G1/G0 (red). (G and H) Subsequently the right parent branch bulges and then bifur-
cates into 2 sister branches (magenta arrows and dots in H). (I) In the proximal regions of the branching lung epithelium
cells begin to exit the cell cycle and enter G1/G0 (red). Abbreviations: mes Dmesenchyme.
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in S/G2/M (green) but
the podocytes in the pre-
sumptive glomeruli were
in G1/G0 (red).
Melanoblast specific
expression of Fucci2a
and estimation of cell
cycle time
To test the tissue spec-
ificity of R26Fucci2aR
mice they were crossed
with Tyr::CreB animals
expressing Cre-recombi-
nase in the neural crest
derived melanocyte line-
age.32 Embryonic mouse
skin from E14.5
Tyr::CreBTgCve/R26Fuc-
ci2aRTg/C animals was
cultured as previously
described33 and analyzed
by live confocal micros-
copy for Fucci2a expres-
sion. As expected
Fucci2a expression was
observed in melano-
blasts, a highly migratory
population of melano-
cyte precursors in the
developing epidermis
(Fig. 8A–F; Movie S4).
It was possible to calcu-
late the relative propor-
tions of Fucci2 labeled
cells and also track the
cells as they migrated
(Fig. 8G–I). Roughly
equal proportions of
mCherry positive and
mVenus positive cells
were observed at the
beginning of the time
lapse sequence in all the samples analyzed (52.57§ 7.46% vs 46.79
§ 7.39% respectively n D 10 embryos) while only a very low per-
centage were observed in the G1/S transition (0.64 § 0.42%).
Strikingly both the mCherry positive and mVenus positive popula-
tions were able to migrate freely with very similar mean (§95%CI)
velocities of 0.58 § 0.07 um/min (n D 1562 tracks from 10
embryos) and 0.52 § 0.05 um/min (n D 1080 tracks from 10
embryos) respectively. Because cells could not be distinguished
from the surrounding keratinocytes after cytokinesis (see the green
cells disappearing inMovie S4) and because our time lapse sequen-
ces were relatively short (»18 hours) it was not possible to follow
individual cells through an entire cell cycle. However it was clear
from the observation of time-lapse sequences that the randomly
migrating melanoblast population was asynchronously cycling.
Furthermore it was previously shown that 2 BrdU doses at 20 min
intervals followed by a 2 hour chase labeled around 60% of the
entire epidermal melanoblast population at E14.5.34 This strongly
suggests that the vast majority if not all melanoblasts are cycling.
We therefore reasoned we could estimate the cell cycle time of the
epidermal melanoblast population using the method described
above for our Flp-Fucci2a 3T3 cells. We calculated the length of S/
G2/M (mean§ 95% CI) in the migrating melanoblast population
to be 7.73 § 0.41 hours (n D 26 cells, 7 independent movies/
embryos). Using this data we were able to derive a cell cycle time
Figure 7. Ex vivo time-lapse imaging of mouse embryonic kidney development. (A–C) Part of an E12.5 kidney after
4.5 hours in culture. The cap mesenchyme contains a larger proportion of cells in G1 (red) than either ureteric bud or
renal vesicles. The renal vesicles in particular contain tight condensations of cells predominately in S/G2/M (green).
(D–F) After 45 hours in culture the S-shaped bodies have formed and while the majority of cells were still cycling it was
clear that the presumptive podocytes of the visceral epithelium were beginning to exit the cell cycle and enter G1/G0
(red). (G–I) By 68.5 hours in culture the majority of podocytes in the mature glomerular structures appeared to have
exited the cell cycle. Abbreviations: cm D cap mesenchyme, ub D ureteric bud; rv D renal vesicle; v.ep D visceral epithe-
lium; p.ep D parietal epithelium; sb D S-shaped body.
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(mean§ 95% CI) of 17.79§ 4.6 hours for the epidermal melano-
blast population at E14.5.
Discussion
We describe the design and validation of Fucci2a, a bicis-
tronic reporter of cell cycle progression. Fucci2a performs
identically to the original Fucci and Fucci2 probes,11,14 but
offers the key advantage of being composed of a single genetic
construct. Table 1 highlights the resources developed during
this study and the repositories in which they have been
housed. In particular the R26Fucci2aR transgenic mouse line
will prove an invaluable tool especially where live imaging and
ex vivo culture are required. A clear advantage of the R26Fuc-
ci2aR allele over the other published mouse models is that
Figure 8. Lineage speciﬁc Fucci2a expression in developing melanoblasts. (A and B) Embryonic skin in culture from a Tyr::CreCve/R26EYFPRTg/C embryo at
E14.5. EYFP positive melanoblasts show their characteristically dendritic morphology. (C–F) Embryonic skin in culture from a Tyr::CreCve/R26Fucci2aRTg/C
positive embryo at E14.5, melanoblasts from all stages of the cell cycle are visible. (G) Quantiﬁcation of the proportions of melanoblast in the 3 cell cycle
phases in E14.5 embryonic skin samples (n D 10 embryos). (H) Automated cell tracking of mVenus-hGem(1/110) labeled melanoblasts (in S/G2/M) over
an 18 hour time-lapse sequence showing the population spread. (I) Automated cell tracking of mCherry-hCdt1(30/120) labeled melanoblasts (in G1)
over an 18 hour time-lapse sequence showing the population spread. Error values in G D 95% conﬁdence intervals.
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because both probes are expressed from a single genomic locus
only one reporter strain is required, simplifying maintenance
and experimental crosses. Furthermore the R26Fucci2aR ani-
mals can be maintained as homozygotes. This is not possible
with the recently published R26p-Fucci2 constitutive allele
(because it is homozygous lethal) or the R26-mCherry-hCdt1
(30/120) and R26-mVenus-hGem (1/110) alleles because they
are integrated at the same genomic locus meaning a mouse
can only be heterozygous for each probe.14 Furthermore,
because the Fucci2a construct is bicistronic, it is likely that
roughly equimolar amounts of each fluorescent probe are pro-
duced which is advantageous for imaging purposes. Previous
reports have suggested that in some contexts the T2A peptide
used in this study can have a cleavage efficiency of >99%.35
In the present study the tight correlation between Fucci2a
fluorescence and cell cycle stage, demonstrated by live imaging
and FACS analysis, suggests that either the cleavage efficiency
of the T2A peptide used is extremely efficient or that any
uncleaved peptide is rapidly degraded because it contains the
degradation signals of both hGeminin and hCdt1.
The present study shows that 3T3 cells modulate the length
of their G1 phase in response to increased serum concentration
and demonstrate the utility of the Fucci2a system to detect a
change in G1 length in response to a relatively subtle increase
from 10% to 15% serum. However the observed concordance
between cell cycle length in sister pairs following a mitosis sug-
gests that as well as extrinsic factors such as confluence and
composition of the culture media there are heritable cell auton-
omous factors that can influence cell cycle length even in trans-
formed cells. This is perhaps not surprising given that a
polyclonal 3T3 cell line was used and that there is known
genetic heterogeneity between clonally selected populations.36
Using our Flp-Fucci2a 3T3 cell line we were able to validate a
method to very accurately estimate cell cycle time from rela-
tively short time lapse sequences by measuring only the length
of S/G2/M. This method shroud be generally applicable and
useful in situations where long time-lapse sequences are difficult
to capture or where it is difficult to track cells though late M-
phase when the Fucci2a probes are both degraded.
In R26Fucci2a mESCs very little accumulation of mCherry-
hCdt1(30/120) in G1 was observed. Similarly 2 previous reports
using mESCs infected with Fucci expressing lentivirus vectors
have described only between 6 and 9% mKO2-hCdt1(30/120)
positive cells with substantial negative populations.37 In both
cases the authors concluded that the lack of mKO2-hCdt1(30/
120) fluorescence in early G1 was because the short G1 phase in
mESCs did not allow enough time for the mKO2-hCdt1(30/
120) probe to accumulate. In the present study it was estimated
that in 3T3 cells it only takes »100 minutes (see Fig. 2) to accu-
mulate detectable levels of mCherry-hCdt1(30/120). G1 length
in mESCs has previously been estimated at around 180
minutes38 which should be enough time for mKO2-hCdt1(30/
120) to accumulate. Therefore if the previously published expla-
nation holds true it seems likely the relative expression level of
the Fucci probes must be affecting how soon during G1 the
hCdt1(30/120)-tagged probe becomes detectable. The expression
level of the R26Fucci2a mESC line described in the present study
is likely to be lower than the lentiviral systems used in the above
papers and this may be the reason we see fewer mCherry-hCdt1
(30/120) labeled cells. In support of this theory in human embry-
onic stem cells (hESCs) both Fucci probes are readily detect-
able39,40 consistent with the longer cell cycle time reported for
hESCs compared to mESCs.41,42
The present study demonstrates the feasibility of using Fuc-
ci2a in ex vivo embryonic organ culture to investigate the role
of proliferation during development. Both probes were readily
detectable in live tissue using only modest confocal laser
power and tissues remained viable throughout the culture
period. We observed Fucci2a expression in all tissues exam-
ined between E10.5 and E15.5. In the embryo, areas that
appeared predominantly red (mCherry-hCdt1 – G1/G0) gen-
erally corresponded with areas of differentiation such as; the
developing digits of the limb bud, the proximal regions of
lung epithelial branches and the stalk of the ureteric bud in
the developing kidney. Using time-lapse confocal microscopy
we captured the growth of lungs, and kidneys. Our data
clearly show active, rapid proliferation driving branching mor-
phogenesis in the lung and kidney. In the kidney the actively
branching regions of the ureteric bud tips were seen to be
highly proliferative while proximal regions of the ureteric bud
began to drop out of the cell cycle. This is consistent with
BrdU based studies of proliferation in a similar organ culture
based system, showing increased BrdU incorporation at the
ureteric bud tips compared to the stalks proximal to these
regions.3 Similarly in the present study, regions of high prolif-
eration were observed in the tips of lung epithelial branches
with lower rates of proliferation in regions proximal to the
tips. Indeed budding tips in the lung epithelium were often so
active that few or no G1 cells could be observed in this region
at all, suggesting cells were moving through the G1 phase in
less than 100 minutes. These results are consistent with a pre-
vious BrdU based proliferation study that showed that while
bud initiation does not require differential proliferation bud
Table 1. Available Fucci2a resources and repository information
Name
Fluorescent
proteins used Repository Notes
Plasmids
pCAG-Fucci2a mCherry, mVenus RBDB CAG
pRosa26-CAG-ﬂoxNeo-
Fucci2a
mCherry, mVenus RBDB R26 targeting
Cell lines
R26Fucci2aR mCherry, mVenus ECACC MESC, CAG
R26Fucci2a mCherry, mVenus ECACC MESC, CAG
Mouse lines
R26Fucci2aR mCherry, mVenus EMMA Cre-inducible
Abbreviations: ECACC D European Collection of Cell Cultures; EMMA D
European Mouse Mutant Archive. RBDB D Riken Bioresource Center DNA
Bank.
All the resources described in this paper will be archived, housed and dis-
tributed from the listed repositories to guarantee access to any research
group.
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outgrowth does.43 However using a BrdU pulse only serves to
highlight cells in S phase during the pulse period, it is a snap-
shot that does not provide information about the cell cycle
status of the non-labeled cells. The R26Fucci2aR reporter
mouse presented here allows one to map cell cycle fate in all
the cells of a developing branch in real-time providing unprec-
edented detail of the fate and cell cycle status of every cell
both spatially and temporally.
Mouse embryonic skin culture has been widely used to study
skin development and more recently in conjunction with live-
imaging to understand the behavior of melanoblasts during
embryonic development.33,44,45 Here for the first time the feasi-
bility of using live cell cycle probes to investigate this lineage is
demonstrated. The labeled populations migrated at speeds that
were consistent with previous reports that did not consider cell
cycle phase.33 This is the first report that demonstrates that
melanoblasts do not modulate their migratory mechanisms dur-
ing cell cycle progression except immediately prior to mitosis
when they pause to divide. This is consistent with a recent
report on the mitotic behavior of chick neural crest cells, show-
ing that they do not lose their position in the migrating popula-
tion as they undergo mitosis.5 The present study includes the
first direct measurement of the cell cycle characteristics in the
migrating melanoblast population. Our estimate of an E14.5
cell cycle time of »17 hours is in close agreement with the
work of Luciani et al34 who estimated the population doubling
time by BrdU labeling and mathematical modeling to be
between 16 and 18 hours. This system, will be very useful to
investigate the large number of mouse mutants with pigment
phenotypes especially those in genes implicated in migration
and proliferation such as Kit, Kitl, Mitf and Pax3.46–49
In conclusion we describe the design and validation of Fuc-
ci2a a novel bicistronic cell cycle reporter system appropriate
for live imaging and FACS analysis. We demonstrate the util-
ity of Fucci2a for quantitative assessment of cell cycle progres-
sion in a stable 3T3 cell line and in mESCs and describe a
method to estimate cell cycle times from short time lapse
sequences without having to track complete mitoses. Further-
more we describe the design, development and characterization
of the R26Fucci2aR mouse model which will prove a valuable
tool for the study of proliferation during mouse embryonic
development when combined with a tissue-specific
Cre-recombinase.
Materials and Methods
Construct design
In order to concatenate mVenus-hGeminin(1/110) and
mCherry-hCdt1(30/120) in both orientations the second gene
was amplified first by PCR using a generic forward primer incor-
porating the T2A sequence preceded byMluI andMfeI restriction
sites (Fucci2t2a_For) and a reverse primer specific to either hGem
(1/110) (hGemKpnI_Rev) or hCdt1(30/120) (hCdt1KpnI_Rev)
flanked by a KpnI restriction site. The resulting amplicon
was restriction cloned as an MluI-KpnI fragment into pCAGiP
(a kind gift fromDr Thomas Pratt). The first gene was then ampli-
fied with a generic forward primer containing an MluI restriction
site (Fucci2_For) and a reverse primer specific to either hGeminin
(hGemMfeI_Rev) or hCdt1(hCdt1MfeI_Rev) flanked by an
MfeI site. The second amplicon was then restriction cloned as an
MfeI/MluI fragment to give pCAG-5C3V and pCAG-5V3C. All
primer sequences are outlined in Table 2, the restriction sites used
are underlined. To make the Flp-targeting plasmids pCDNA5–
5C3V and pCDNA5–5V3C the plasmid pCDNA5/Frt (Life
Technologies, http://www.lifetechnologies.com/order/catalog/
product/V601020) was modified with a polylinker (see Table 2
for oligonucleotide sequences—pCDNAPoly_For and pCDNA-
Poly_Rev) cloned between the NheI and ApaI restriction sites and
introducing EcoRI and AscI restriction sites. Subsequently Fucci–
5V3C and Fucci2–5C3V were cloned between the EcoRI and
AscI restriction sites. To generate pRosa26-CAG-floxNeo-
Fucci2a, pCAGiP was modified with a polylinker (pCAGPoly_
For and pCAGPoly_Rev) allowing the subcloning of CAG-
Fucci2-pA as a SalI/HindIII fragment. A floxed Neo cassette was
then restriction cloned between CAG and Fucci2 as an EcoRI frag-
ment from the plasmid pCAGfloxNEOpA (a kind gift from Prof
Ian Chambers). The pRosa26-PA plasmid (Addgene, https://
www.addgene.org/21271) was modified with a polylinker
(pRosa26-pA_For and pRosa26_pA_Rev) so that the AscI and
PacI sites were inverted. Subsequently the entire CAG-floxNeopA-
Fucci2–5C3V-pA construct was transferred as a PacI/AscI frag-
ment so that it was aligned in the opposite direction to the endoge-
nous Rosa26 promoter to make pRosa26-CAG-floxNeo-Fucci2a.
Generation of stable Flp-Fucci2a cell lines
Flp-in 3T3 cells (Life Technologies, https://www.
lifetechnologies.com/order/catalog/product/R76107) were grown
to confluence in a T75 tissue culture flask under standard condi-
tions. The Neon electroporation system (Life Technologies, https://
www.lifetechnologies.com/order/catalog/product/MPK5000S) was
Table 2. Oligonucleotide sequences used for vector construction
Sequence (50 - 30)
Fucci2t2a_For CGGCACACGCGTTGTCAACAATTGGAAGGCCGTGGCTC
TCTTCTCACTTGTGGCGATGTCGAAGAGAATCCTGGAC
CCATGGTGAGCAAGGGCGAGGAG
Fucci2_For CGGCACACGCGTATGGTGAGCAAGGGCGAGGAG
hGemKpnI_Rev GCCGTCGGTACCTTACAGCGCCTTTCTCCGTTTTTCTG
hCdt1KpnI_Rev GCCGTCGGTACCTTAGATGGTGTCCTGGTCCTGCG
hGemMfeI_Rev GCCGTCCAATTGCAGCGCCTTTCTCCGTTTTTCTG
hCdt1MfeI_Rev GCCGTCCAATTGGATGGTGTCCTGGTCCTGCG
pCDNAPoly_For CTAGC GAATTCACGCGTACATGTGGCGCGCCGGGCC
pCDNAPoly_Rev CGGCGCGCCACATGTACGCGTGAATTCG
pCAGPoly_For TCGAGTTAATTAAGTCGACCTTAAGAAGCTTGGCGCGCC
CTGCA
pCAGPoly_Rev GGGCGCGCCAAGCTTCTTAAGGTCGACTTAATTAAC
pRosa26-pA_For CGGGCGCGCCTTAATTAAA
pRosa26-pA_Rev CGCGTTTAATTAAGGCGCGCCCGAT
The oligonucleotide sequences listed above were used in the production of
the Fucci2a constructs described.
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used to co-transfect the cells with the modified pCDNA5/FRT plas-
mids described above and the pOG44 Flp recombinase expressing
plasmid (Life Technologies, https://www.lifetechnologies.com/
order/catalog/product/V600520). Briefly, the cells were trypsinised,
washed in PBS and resuspended in Buffer R. 18ug of pOG44 and
3ug of the targeting construct were added to each tube. Each tube
was then split into 2 £ 100 ul electroporations (2 pulses: 1,350V,
20ms) and pooled into a single T75 flask containing pre-warmed
OPTIMEM (Life Technolgies, https://www.lifetechnologies.com/
order/catalog/product/31985070) and incubated overnight. On the
second day cells were transferred into dulbeccos modified eagle
medium (DMEM) containing, 10% fetal calf serum, 1% Penicil-
lin/Streptomycin and 100mg/ml Hygromycin B. After 14 days of
Hygromycin B selection the polyclonal cell lines were passaged as
normal and used for subsequent analyses.
Fluorescence microscopy and live imaging of Flp-Fucci2a
cell lines
For the initial screening of the Flp-Fucci2a-5V3C and Flp-
Fucci2a-5V3C cell lines, single images were captured on a wide-
field Nikon Ti fluorescence microscope with a 20x dry lens. To
compare the nuclear to cytoplasmic ratio of the Fucci2a probes
and to measure the length of mitosis, cells were seeded in glass
bottomed dishes in DMEM (10% or 15% FCS, 1% Pen/Strep).
The dish was enclosed in an environmental chamber maintained
at 37C with 5% CO2 in air. Images were captured using a
Nikon C1 confocal system at 20 minute time intervals. For
Movie S1 and the montage in Figure 2 cells were seeded at low
densities in glass dishes and cultured in DMEM (10% FCS, 1%
Pen/Strep) on the stage of Nikon TiE microscope equipped with
a Nikon perfect focus system. The dish was enclosed in an envi-
ronmental chamber maintained at 37C with 5% CO2 in air.
Images were captured with a 40x dry objective every 20 minutes
using a Photometrics Evolve 512 EMCCD camera and a Lumen
Dynamics Xcite 120Q light source (120W mercury vapor).
ES Cell targeting and generation of transgenic mice
E14 ES cells were maintained in Glasgow Minimum Essential
Medium (GMEM) supplemented with 10% fetal calf serum,
0.1mM non-essential amino acids, 2mM L-Glutamine, 1mM
sodium pyruvate, 0.1mM b-mercaptoethanol and 106 units/L
LIF. They were electroporated with linearized pRosa26-CAG-
floxNeo-Fucci2a plasmid using standard procedures. Clones
were picked after 14 days of G418 selection. Colonies were
screened by PCR across the Rosa26 50 homology arm using the
primers Xu_Wt_For50 and Rosa5_R1 (See Fig. 4 and Table 3)
to generate a 1.4kb targeted band. A second control PCR was
conducted to demonstrate DNA integrity using the primers
Wt_For and Wt_Rev15 to generate a 450bp wildtype band from
the Rosa26 locus. Correct targeting was confirmed on the positive
clones by PCR amplification of a 4kb targeted band across the
Rosa26 30 homology arm using the primers Rosa3_F1 and
Rosa3_R2, all primer sequences are outlined in Table 3. All
PCR reactions were carried out using 50 ng genomic DNA using
Phusion Hotstart II DNA polymerase (Thermo Fisher Scientific,
http://www.thermoscientificbio.com/pcr-enzymes-master-mixes-
and-reagents/phusion-hot-start-ii-high-fidelity-dna-polymerase/)
with GC buffer according to the manufacturers standard reaction
conditions. The thermocycling conditions for each reaction are
outlined in Table 4. For the mESC differentiation assay, cells
were cultured as above but without LIF and in the presence of
1mM retanoic acid (RA) for 4 days. Transgenic mice were pro-
duced by blastocyst injection of R26Fucci2aR ES cells according
to standard methods. Germline transmission was identified after
a single round of ES cell blastocyst injections. Subsequent inter-
crosses generated R26Fucci2aRC/C, R26Fucci2aRC/Tg and R26Fuc-
ci2aRTg/Tg offspring at near Mendelian ratios.
Maintenance and genotyping of mice
All animal work was approved by a University of Edinburgh
internal ethics committee and was performed in accordance
with institutional guidelines under license by the UK Home
Office. Mice were maintained in the animal facilities of the
University of Edinburgh. R26Fucci2aR mice were genotyped
using a duplex PCR reaction with the primers R26_Wt_For,
R26_Wt_Rev and F2A_Rev (Table 3) the R26_Wt_Rev
primer was used at 50mM rather than 100mM; all other condi-
tions were the same as described above, and the cycling condi-
tions are detailed in Table 4.
FACS analysis
Flow Cytometry sorting of Flp-Fucci2a cells was performed
using a FACS Aria2 SORP cell sorter (Becton Dickinson)
equipped with a 405nm violet laser, a 488nm blue laser and a
560nm yellow-green laser. mVenus was detected using the
488nm laser and a 525/50nm bandpass filter. mCherry was
detected using the 560nm laser and a 610/20nm bandpass fil-
ter. Flp-Fucci2a cells were sorted into mCherry positive, mVe-
nus positive, double positive and negative fractions. The cells
Table 3. Oligonucleotide sequences used for PCR reactions
Sequence (50 - 30)
Oligonucleotide sequences used
for screening ES cells:
Wt_For AAAGTCGCTCTGAGTTGTTAT
Wt_Rev GGAGCGGGAGAAATGGATATG
Xu_Wt_For GGCGGACTGGCGGGACTA
Rosa5_R1 CCGTAAATAGTCCACCCATTGACG
Rosa3_F1 GGTGGGCTCTATGGCTTCTG
Rosa3_R2 GGAGTAGTTACTCCACTTTCAAG
Oligonucleotide sequences used
for genotyping mice:
R26_Wt_For CAAAGTCGCTCTGAGTTGTTATCAG
R26_Wt_Rev GGAGCGGGAGAAATGGATATGAAG
F2A_Rev TGGCGGCCGCTCGAGATGAATC
The oligonucleotide sequences listed above were used to PCR screen
R26Fucci2aR mESC clones, conﬁrm homologous recombination across both
targeting arms and genotype the resulting mouse lines.
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were subsequently fixed in 70% Ethanol at ¡20C overnight.
The following day they were briefly stained with DAPI (5mg/
ml in PBS) and analyzed for DNA content using the 405nm
laser and a 450/50nm bandpass filter. FACSDiVa Version 6.1
(BD) was used to operate the instrument and to analyze the
data.
Embryonic skin culture
Embryonic mouse skin was dissected from E14.5 embryos and
mounted on a custom made imaging clip filled with 1% agarose
to support the tissue. The skin was then clamped with the epider-
mal side against a lumox gas-permeable membrane (Greiner Bio-
One; http://www.greinerbioone.com/en/row/articles/catalog/
articles/423_11/) in a custom made culture chamber filled with
DMEM (10% FCS, 1% Glutamax, 1% Penicillin/Streptomy-
cin). The chamber was placed on the stage of an inverted Nikon
C1 confocal microscope surrounded by an environmental cham-
ber providing 5% CO2 in air and maintained at a constant stage
top temperature of 37C. Confocal Z-stacks were captured every
2 minutes for 18 hours.
Lung and kidney culture
To capture kidneys at low magnification an inverted epifluor-
escent microscope equipped with a 4x objective was used. For
high resolution confocal time lapse of lungs and kidneys the tis-
sue was immobilized with reduced growth factor matrigel (BD
biosciences) on lumox gas-permeable membranes mounted in a
custom chamber and submerged in DMEM (10% FCS, 1% Glu-
tamax, 1% Penicillin/Streptomycin). The chamber was placed on
the stage of an inverted Nikon A1R confocal microscope sur-
rounded by an environmental chamber providing 5% CO2 in air
and maintained at a constant stage top temperature of 37C.
Images were captured with a 20x objective every 30 minutes
through roughly 60 mm z-stacks.
Image analysis
All image analysis tasks were performed using custom written
macros for the Fiji51 distribution of ImageJ an open source image
anlaysis package based on NIH Image.52 To track Flp-Fucci2a
3T3 cells and analyze the length of cell cycle phases a semi
automated tracking method was used. Intensity was measured
as the integrated density of a 10 pixel circular ROI that was
centered on the local maxima within a cell’s nucleus. Pairs of
cells were tracked from the first frame after cytoplasmic cleav-
age until the frame before cleavage at the next mitosis. The
intensity values for each track were normalized (between 0-1)
and a 3-point rolling average was applied to smooth the data.
Peaks were called as positive for mCherry or mVenus if the
normalized integrated density was greater than 0.15. To auto-
matically track mCherry and mVenus labeled melanoblasts a
modified version of the wrMTrck plugin (http://www.phage.
dk/plugins/wrmtrck.html) was used on segmented TIFF stacks
of each channel, the script used relied on Gabriel Landini’s
morphology collection (http://www.mecourse.com/landinig/
software/software.html).
Statistics
All statistical tests were performed using the ‘R’ statistics
package, an open source software package based on the ‘S’ pro-
gramming language (http://www.R-project.org). The length of
cell cycle phases after culture in 10% or 15% serum were com-
pared with students’ t-tests using Bonferroni correction for mul-
tiple testing. The nuclear to cytoplasmic ratios of mCherry and
mVenus in Flp-3T3-Fucci2a cells were compared using a one-
way analysis of variance (ANOVA) followed by pairwise post
hoc tests using Tukey’s honest significant difference (HSD) test.
The correlation between mitosis times for daughter cells and
randomly matched pairs were compared using a Spearman’s
rank order test.
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Table 4. PCR conditions for all reactions
Rosa26 Wt (ES) Rosa26 50 (ES) Rosa26 30 (ES) Genotyping (Mice)
Temp Time Temp Time Temp Time Temp Time
Initial denaturation 98 3min 98 3min 98 3min 98 3min
Denaturation 98 10s 98 10s 98 10s 98 10s
Annealing 60 10s 66 10s 68 10s 68 10s
Extension 72 30s 72 30s 72 1min 72 30s
Final Extension 72 5min 72 5min 72 5min 72 5min
Hold 10 Forever 10 Forever 10 Forever 10 Forever
All reactions were for 35 cycles through the steps in bold.
The above PCR conditions were used to PCR screen R26Fucci2aR mESC clones, conﬁrm homologous recombination across both targeting arms and geno-
type the resulting mouse lines.
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